Oxamflatin

Suppliers

Names

[ CAS No. ]:
151720-43-3

[ Name ]:
Oxamflatin

[Synonym ]:
2-Penten-4-ynamide, N-hydroxy-5-[3-[(phenylsulfonyl)amino]phenyl]-, (2E)-
(2E)-N-hydroxy-5-{3-[(phenylsulfonyl)amino]phenyl}pent-2-en-4-ynamide
(2E)-N-Hydroxy-5-{3-[(phenylsulfonyl)amino]phenyl}-2-penten-4-ynamide
(2E)-5-[3-(Phenylsulfonylamino)phenyl]-pent-2-en-4-ynohydroxamic acid
(E)-5-[3-(benzenesulfonamido)phenyl]-N-hydroxypent-2-en-4-ynamide

Chemical & Physical Properties

[ Density]:
1.4±0.1 g/cm3

[ Molecular Formula ]:
C17H14N2O4S

[ Molecular Weight ]:
342.369

[ Exact Mass ]:
342.067413

[ PSA ]:
103.88000

[ LogP ]:
3.26

[ Index of Refraction ]:
1.686

[ Storage condition ]:
2-8℃

Safety Information

[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter

[ Safety Phrases ]:
S22

[ RIDADR ]:
NONH for all modes of transport

[ HS Code ]:
2935009090

Synthetic Route

Click to get detail synthetic route

Precursor & DownStream

Precursor

  • Dehydroxyamino Oxamflatin Acid
  • tert-Butyl (3-iodophenyl)carbamate

DownStream

Customs

[ HS Code ]: 2935009090

[ Summary ]:
2935009090 other sulphonamides VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:35.0%

Articles

Survival motor neuron gene 2 silencing by DNA methylation correlates with spinal muscular atrophy disease severity and can be bypassed by histone deacetylase inhibition.

Hum. Mol. Genet. 18 , 304-17, (2009)

Spinal muscular atrophy (SMA), a common neuromuscular disorder, is caused by homozygous absence of the survival motor neuron gene 1 (SMN1), while the disease severity is mainly influenced by the numbe...


More Articles

Related Compounds

  • OXAMFLATIN
  • Oxamflatin
  • Dehydroxyamino Oxamflatin Acid
  • 7-[(2-Fluorophenyl)methyl]-1,3,4,9-tetramethyl-4,5a-dihydropurino[8,7-c][1,2,4]triazin-5-ium-6,8-dione
  • [5-(4-Chloroanilino)triazolidin-4-yl]-[4-(2-methoxyphenyl)piperazin-1-yl]methanone
  • 6-cyclohexyl-2-ethyl-4,7,8-trimethyl-9aH-purino[7,8-a]imidazol-9-ium-1,3-dione
  • N-(1-cyanocyclopentyl)-2-(2,2-dimethyl-1-oxo-1lambda4-thiomorpholin-4-yl)acetamide
  • [5-(2-Fluoroanilino)triazolidin-4-yl]-[4-(4-fluorophenyl)piperazin-1-yl]methanone
  • 3,9-dimethyl-7-[(2-methylphenyl)methyl]-4,5a-dihydro-1H-purino[8,7-c][1,2,4]triazin-5-ium-6,8-dione
  • 7-[(4-Chlorophenyl)methyl]-1,3,9-trimethyl-4,5a-dihydropurino[8,7-c][1,2,4]triazin-5-ium-6,8-dione
  • n-(2-Ethyl-4-hydroxybutyl)-2-fluorobenzenesulfonamide
  • 1-(2-ethoxyethyl)-3,9-dimethyl-7-[(4-methylphenyl)methyl]-5a,9a,10,10a-tetrahydro-4H-purino[8,7-c][1,2,4]triazine-6,8-dione
  • 7-ethyl-3,9-dimethyl-1-[(3-methylphenyl)methyl]-5a,9a,10,10a-tetrahydro-4H-purino[8,7-c][1,2,4]triazine-6,8-dione